{"id":14063,"date":"2023-09-21T14:50:18","date_gmt":"2023-09-21T14:50:18","guid":{"rendered":"https:\/\/dev.haugpartners.com\/?post_type=article&p=14063"},"modified":"2024-09-26T09:05:39","modified_gmt":"2024-09-26T09:05:39","slug":"d-c-circuit-dismisses-ftc-antitrust-suit-exclusive-pharma-patent-licenses-remain-permissible-under-the-patent-act","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/d-c-circuit-dismisses-ftc-antitrust-suit-exclusive-pharma-patent-licenses-remain-permissible-under-the-patent-act\/","title":{"rendered":"D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act"},"featured_media":0,"template":"","categories":[98],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/14063"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=14063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=14063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}